Cefonicid sodium (CAS 61270-78-8)

Cefonicid sodium, a second-generation cephalosporin antibiotic, has been a subject of considerable interest in scientific research due to its mechanism of action and potential applications in microbiology and antimicrobial studies. This compound exerts its antibacterial effects by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), thus disrupting the formation of peptidoglycan and leading to bacterial cell lysis. Researchers have utilized cefonicid sodium as a tool to investigate bacterial cell wall biosynthesis pathways and the molecular mechanisms underlying bacterial resistance to cephalosporin antibiotics. Studies have focused on elucidating the structural determinants of cefonicid′s interactions with PBPs and exploring the mechanisms by which bacteria develop resistance to this class of antibiotics. Furthermore, cefonicid sodium has been employed in microbiological research to study bacterial susceptibility patterns, mode of action, and potential synergistic effects with other antimicrobial agents. Additionally, its pharmacokinetic properties and tissue distribution have been investigated to optimize dosing regimens and improve treatment outcomes. Beyond antimicrobial research, cefonicid sodium has found applications in biochemical and molecular biology studies as a tool to probe bacterial physiology, antibiotic resistance mechanisms, and the development of novel antimicrobial strategies. With the continuous evolution of antibiotic resistance and the emergence of multidrug-resistant bacterial strains, cefonicid sodium remains a valuable asset in scientific investigations aimed at understanding bacterial pathogenesis and developing effective strategies to combat antimicrobial resistance.